Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
Hye‐Kyung Park(Ulsan National Institute of Science and Technology), Byoung Heon Kang(Cheongju University)
Cited by 60
Related Papers
Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
|Experimental & Molecular Medicine|2020|143
Targeting the Mitochondrial Chaperone TRAP1 Alleviates Vascular Pathologies in Ischemic Retinopathy
|Advanced Science|2023|18
Pseudohypoxic stabilization of HIF1α via cyclophilin D suppression promotes melanoma metastasis
|Signal Transduction and Targeted Therapy|2025|4